[et_pb_section fb_built=”1″ _builder_version=”3.23.1″][et_pb_row _builder_version=”3.23.1″][et_pb_column type=”4_4″ _builder_version=”3.23.1″][et_pb_video src=”https://www.youtube.com/watch?v=goh1bXXa6Uc&feature=youtu.be” _builder_version=”3.23.1″][/et_pb_video][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.23.1″][et_pb_row _builder_version=”3.23.1″][et_pb_column type=”4_4″ _builder_version=”3.23.1″][et_pb_text _builder_version=”3.23.1″]

Researchers have for the first time succeeded in conquering a chronic infection of the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a permanent cure.
#hbv #hepatitisb #cure
Karin Wisskirchen, Janine Kah, Antje Malo, Theresa Asen, Tassilo Volz, Lena Allweiss, Jochen M. Wettengel, Marc Lütgehetmann, Stephan Urban, Tanja Bauer, Maura Dandri, Ulrike Protzer. T cell receptor grafting allows virological control of hepatitis B virus infection. Journal of Clinical Investigation, 2019; DOI: 10.1172/JCI120228
https://www.jci.org/articles/view/120228gs.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]